ly2127399
Showing 1 - 14 of 14
Kidney Failure, Chronic Trial in Indianapolis (LY2127399)
Completed
- Kidney Failure, Chronic
- LY2127399
-
Indianapolis, IndianaFor additional information regarding investigative sites for thi
May 11, 2018
Systemic Lupus Erythematosus, Connective Tissue Disease, Autoimmune Disease Trial in Irving (LY2127399, Placebo)
Terminated
- Systemic Lupus Erythematosus
- +2 more
- LY2127399
- Placebo
-
Irving, TexasFor additional information regarding investigative sites for thi
May 16, 2018
Arthritis, Rheumatoid Trial in Worldwide (LY2127399, Placebo)
Completed
- Arthritis, Rheumatoid
- LY2127399
- Placebo
-
Birmingham, Alabama
- +44 more
Nov 10, 2018
Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (LY2127399, Placebo)
Completed
- Relapsing-Remitting Multiple Sclerosis
- LY2127399
- Placebo
-
Phoenix, Arizona
- +62 more
Nov 10, 2018
Rheumatoid Arthritis Trial in Worldwide (LY2127399, Placebo)
Completed
- Rheumatoid Arthritis
- LY2127399
- Placebo
-
Huntsville, Alabama
- +47 more
Jun 11, 2018
Systemic Lupus Erythematosus, Connective Tissue Disease, Autoimmune Disease Trial in Worldwide (LY2127399, Placebo every 2
Completed
- Systemic Lupus Erythematosus
- +2 more
- LY2127399
- +2 more
-
Anniston, Alabama
- +184 more
Jun 18, 2018
Systemic Lupus Erythematosus, Connective Tissue Disease, Autoimmune Disease Trial in Worldwide (LY2127399, Placebo every 2
Completed
- Systemic Lupus Erythematosus
- +2 more
- LY2127399
- +3 more
-
Birmingham, Alabama
- +191 more
Jun 11, 2018
Rheumatoid Arthritis Trial in Worldwide (LY2127399, Placebo Q4W, Placebo Q2W)
Terminated
- Rheumatoid Arthritis
- LY2127399
- +2 more
-
Birmingham, Alabama
- +200 more
May 11, 2018
Rheumatoid Arthritis Trial in Worldwide (LY2127399, Placebo)
Completed
- Rheumatoid Arthritis
- LY2127399
- Placebo
-
Birmingham, Alabama
- +212 more
Mar 24, 2018
Rheumatoid Arthritis Trial in Worldwide (LY2127399, Placebo Q2W, Placebo Q4W)
Terminated
- Rheumatoid Arthritis
- LY2127399
- +3 more
-
Birmingham, Alabama
- +233 more
May 4, 2018